Dynavax Technologies (DVAX)
(Real Time Quote from BATS)
$11.26 USD
+0.05 (0.45%)
Updated Apr 29, 2024 11:50 AM ET
3-Hold of 5 3
D Value F Growth A Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
DVAX 11.26 +0.05(0.45%)
Will DVAX be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for DVAX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DVAX
Dynavax Technologies (DVAX) Reports Break-Even Earnings for Q4
Pacira (PCRX) Preliminary '23 Revenues Solid, Exparel Strong
DVAX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Axsome (AXSM) Stock Rises on Stellar Q4 Preliminary Results
Dynavax Technologies (DVAX) Is a Great Choice for 'Trend' Investors, Here's Why
Collegium (COLL) Shares Rise on Financial Outlook for 2024
Other News for DVAX
Dynavax to Report First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024
Dynavax Appoints Interim CFO During MacDonald’s Leave
Dynavax Technologies: Still A Believer
Dynavax: Holding Firm Despite Its Missing Cash Cow
Dynavax (NASDAQ:DVAX): Potential Growth at a Rich Valuation